THE STUDY OF BIOEQUIVALENCE OF TWО EZETIMIB DRUGS AFTER SINGLE ORAL ADMINISTRATION IN HEALTHY VOLUNTEERS ArticleTolkacheva V.V., Malaya I.P., Bagmanova N.K., Kobalava Z.D.Consilium Medicum. Том 21. 2019. С. 87-91
INCIDENCE AND PROBABILITY OF HEART FAILURE WITH PRESERVED EJECTION FRACTION AMONG HIGH RISK HYPERTENSIVE PATIENTS. ArticleSoloveva A., Babaeva L., Safarova A., Kobalava Z., Gudieva K., Islamova M., Ammar R., Karaulova Y.European Journal of Heart Failure. Том 21. 2019. С. 389-390
RENIN LEVEL AND HYDRATION STATUS IN ELDERLY HYPERTENSIVE PATIENTS ArticleKobalava Z., Chomova I., Shavarova E.Journal of Hypertension. Том 37. 2019.
PROGNOSTIC VALUE OF BIOIMPEDANCE VECTOR ANALYSIS-ASSESSED CACHEXIA IN PATIENTS WITH DECOMPENSATED HEART FAILURE ArticleKlimenko A., Rakisheva A., Villevalde S., Kobalava Z.European Journal of Heart Failure. Том 21. 2019. С. 269-270
THE IMPACT OF APOC3 AND APOE GENE POLYMORPHISMS ON RESPONSE TO STATIN THERAPY IN ACUTE MYOCARDIAL INFARCTION ArticleTeterina M., Geraskin A., Potapov P., Babaeva L., Pisaryuk A., Goreva L., Balatskiy A., Meray I., Kobalava Z.European Heart Journal. Том 40. 2019. С. 430-430
CONCERNING THE “REPRESSION” OF Ω-3 POLYUNSATURATED FATTY ACIDS BY ADEPTS OF EVIDENCE-BASED MEDICINE ArticleTorshin I.Y., Gromova O.A., Kobalava Z.D.FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. Том 12. 2019. С. 91-114
THE INCIDENCE OF THE FIRST ONSET DIAGNOSED TYPE 2 DIABETES MELLITUS IN PATIENTS WITH CARDIOVASCULAR DISEASES ArticleMedovchshikov V.V., Yeshniyazov N.B., Tereshchenko E.A., Khasanova E.R., Kobalava Z.D.European Journal of Heart Failure. Том 21. 2019. С. 135-135
HYPERTENSIVE PATIENTS WITH RHEUMATOID ARTHRITIS ARE CHARACTERIZED BY HIGHER LEVELS OF THE OFFICE BLOOD PRESSURE AND WORSE CONTROL OF CENTRAL BLOOD PRESSURE COMPARED TO THE CONTROLS ArticleKobalava Z., Velmakin S., Troitskaya E.Journal of Hypertension. Том 37. 2019.
FREQUENCY AND SEVERITY OF GERIATRIC SYNDROMES IN ELDERLY PATIENTS WITH ACUTE CORONARY SYNDROME IN RELATION TO LEFT VENTRICULAR EJECTION FRACTION ArticleSoseliya N.N., Lukina O., Soloveva A., Villevalde S., Kobalava Z., Metelkin A.European Journal of Heart Failure. Том 21. 2019. С. 540-541
THE FIRST RUSSIAN CONSENSUS ON QUANTITATIVE ASSESSMENT OF TREATMENT OUTCOME ArticleArutyunov A.G., Bojcov S.A., Viktorova I.A., Vlasov V.V., Voevoda M.I., Vorob'yov P.A., Drapkina O.M., Zadionchenko V.S., Zarubina T.V., Zyryanov S.K., Karpov R.S., Kobalava Z.D., Kolbasnikov S.V., Lazebnik L.B., Livzan M.A., Malyavin A.G., Martynov A.I., Medvedeva I.V., Moiseev S.V., Napalkov D.A. ...Medical News of North Caucasus. Том 14. 2019. С. 283-301
EVALUATION OF LUNG ULTRASOUND FOR DIFFERENTIAL DIAGNOSIS OF PNEUMONIA AND HEART FAILURE DECOMPENSATION ArticleZorya O.O., Omar S., Bayarsaikhan, Rachina S.A., Kobalava Z.D.European Journal of Heart Failure. Том 21. 2019. С. 434-434
ELEVATED HEART RATE IN HYPERTENSION AND CORONARY ARTERY DISEASE: RISK FACTOR OR RISK MARKER IN PATIENTS WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION ArticleKokhan E.V., Kiyakbaev G.K., Kobalava Z.D.Arterial Hypertension. Том 25. 2019. С. 389-406
WORSE OFFICE AND 24-HOUR BRACHIAL AND CENTRAL AORTIC BLOOD PRESSURE MONITORING PROFILE IN PATIENTS WITH RHEUMATOID ARTHRITIS COMPARED TO CONTROLS ArticleTroitskaya E., Velmakin S., Villevalde S., Kobalava Z.Annals of the Rheumatic Diseases. Том 78. 2019. С. 1632-1633
PHASE II STUDY OF SINGLE/REPEATED DOSES OF ACUMAPIMOD (BCT197) TO TREAT ACUTE EXACERBATIONS OF COPD ArticleStrâmbu I.R., Kobalava Z.D., Magnusson B.P., Mackinnon A., Parkin J.M.COPD: Journal of Chronic Obstructive Pulmonary Disease. Том 16. 2019. С. 344-353
OFFICE AND 44-HOUR AMBULATORY BLOOD PRESSURE AND CENTRAL HAEMODYNAMIC PARAMETERS IN THE PATIENTS WITH END-STAGE RENAL DISEASES UNDERGOING HAEMODIALYSIS ArticleTrukhanova M.A., Orlov A.V., Tolkacheva V.V., Troitskaya E.A., Villevalde S.V., Kobalava Z.D.Kardiologiia. Том 59. 2019. С. 63-72